It is not clear whether Percutaneous Coronary Intervention (PCI) is as effective and safe as Coronary Artery Bypass Grafting (CABG) for left main coronary artery disease. We aimed to perform a systematic review and meta-analysis of all randomized controlled trials (RCTs) that compared PCI and CABG in left main coronary disease.
We searched PubMed, EMBASE, Cochrane, Scopus and relevant references for RCTs (inception through, November 20, 2016 without language restrictions) and performed meta-analysis using random effects model. All-cause mortality, Myocardial infarction, revascularization rate, stroke,, major adverse cardiac and cerebrovascular events (MACCE) were the measured outcomes.
6 RCTs with a total population of 4700 were analyzed. There was no difference in all-cause mortality at 30-day, 1-year and 5-year (1.8% vs. 1.1%; OR 0.60; 95%CI 0.26-1.39;P=0.23;I(2) =9%) follow up between PCI and CABG. CABG group had less MI at 5-year follow up than PCI (5% vs. 2.5%; OR 2.04; CI 1.30-3.19; P=0.002;I(2) =1%). Revascularization rate favored CABG in 1-year (8.6% vs 4.5%; OR 2; CI 1.46-2.73; P<0.0001;I(2) =45%) and 5-year (15.9% vs. 9.9%;OR 1.73; CI 1.36-2.20; P<00001;I(2) =0%)follow up. Though stroke rate was lower in PCI group at 1-year there was no difference in longer follow up. MACCE at 5-year favored CABG (24% vs. 18%; OR 1.45; CI 1.19-1.76; P=00001;I(2) =0%). On subgroup analysis, MAACE was not different between two groups in low to intermediate Syntax group while it was higher for PCI group with high Syntax group.
PCI could be as safe and effective as CABG in a select group of left main coronary artery disease patients. This article is protected by copyright. All rights reserved.